Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the (a) pricing and (b) reimbursement system for multi-indication medicines does not disadvantage patients with (i) rare and (ii) ultra-rare conditions.

I refer the Hon. Member to the answers my Rt Hon. Friend, the Minister of State for Health gave on 1 September 2025 to Questions 69240, 69241, and 69242.